Efficacy and safety of a VWF/FVIII concentrate (wilate®) in inherited von Willebrand disease patients undergoing surgical procedures-Reference-Cited by-同舟云学术

Efficacy and safety of a VWF/FVIII concentrate (wilate®) in inherited von Willebrand disease patients undergoing surgical procedures

Published:2016-12-27 Issue:2 Volume:23 Page:264-272
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Srivastava A.¹,Serban M.²,Werner S.³,Schwartz B. A.³,Kessler C. M.⁴,

Affiliation:

1. Department of Haematology; Christian Medical College; Vellore India

2. University Emergency Pediatric Hospital Louis Turcanu; Timisoara Romania

3. Octapharma Clinical Research; Hoboken NJ USA

4. Hemophilia and Thrombosis Comprehensive Treatment Center and the Division of Coagulation; Georgetown University Medical Center; Washington DC USA

Funder

Biotest

Baxter International

Novo Nordisk

CSL Behring

Baxalta

Bayer

Grifols

Octapharma

Roche

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.13106/fullpdf

Reference24 articles.

1. von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy;Lillicrap;Blood,2013

2. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA);Nichols;Haemophilia,2008

3. von Willebrand's disease: from discovery to therapy - milestones in the last 25 years;Kreuz;Haemophilia,2008

4. Goodeve A James P von Willebrand Disease http://www.ncbi.nlm.nih.gov/books/NBK7014/

5. Prophylactic efficacy and pharmacokinetically guided dosing of a von Willebrand factor/factor VIII concentrate in adults and children with von Willebrand's disease undergoing elective surgery: a pooled and comparative analysis of data from USA and European Union clinical trials;Mannucci;Blood Transfus,2013

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of a 1:1 ratio VWF/FVIII concentrate in patients with von Willebrand disease;Haemophilia;2024-07-15

2. Hemostatic management of von Willebrand disease during childbirth with a plasma-derived von Willebrand factor/factor VIII concentrate;Journal of Thrombosis and Haemostasis;2024-06

3. Key Drivers of Coagulation Factor Use in Von Willebrand Disease During Hospitalization: An Overview of the French BERHLINGO Cohort;Clinical Drug Investigation;2023-11-30

4. Targeting von Willebrand disease: the current status and future directions of management therapies;Expert Review of Hematology;2023-10-12

5. Pharmacokinetic-Pharmacodynamic Comparison of Recombinant and Plasma-Derived von Willebrand Factor in Patients with von Willebrand Disease Type 3;Journal of Blood Medicine;2023-06